Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis

BACKGROUND: HBV and HCV reactivation have been widely reported in patients undergoing immunosuppressive therapy (IT); however, few data are available on the risk of reactivation in patients with psoriasis receiving IT. The aim of our study was to assess the prevalence of HBV and HCV infection in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisco, Filomena, Guarino, Maria, La Bella, Serena, Di Costanzo, Luisa, Caporaso, Nicola, Ayala, Fabio, Balato, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279461/
https://www.ncbi.nlm.nih.gov/pubmed/25523080
http://dx.doi.org/10.1186/s12876-014-0214-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279461/
https://www.ncbi.nlm.nih.gov/pubmed/25523080
http://dx.doi.org/10.1186/s12876-014-0214-x

Ejemplares similares